Based on Your Reading:
Get a Mesothelioma Treatment Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Pleurectomy and Decortication (P/D) is a lung-sparing surgery for pleural mesothelioma that removes the affected pleura and visible tumor masses. This procedure aims to improve quality of life by relieving symptoms while preserving lung function.
Written by Karen Selby, RN | Medically Reviewed By Dr. Andrea Wolf | Edited By Walter Pacheco | Last Update: October 31, 2024
Pleurectomy/decortication (P/D) surgery is a two-part procedure. The pleurectomy involves opening the chest cavity and removing the pleural lining around the lung and other visible tumor masses. Unlike more radical surgeries, such as extrapleural pneumonectomy (EPP), P/D preserves lung tissue, allowing patients to maintain lung function post-surgery.
Pleurectomy/decortication surgery is an effective treatment for mesothelioma in the lung’s lining, also called pleural mesothelioma. Removing the pleural tissue and other cancerous growths in the lung can extend survival and significantly increase quality of life.
P/D surgery is most effective as part of a comprehensive treatment approach. Studies show that this kind of multimodal approach can increase survival rates. Surgeons use postoperative chemotherapy, radiation therapy or immunotherapy to eliminate any remaining cancer cells. In addition, using adjuvant therapies can prevent or delay cancer recurrence.
The pleurectomy/decortication procedure is broken down into two key steps. Each step is vital in effectively treating pleural mesothelioma.
In the pleurectomy portion (also known as a parietal pleurectomy) of P/D surgery, the surgeon opens the chest cavity and removes the outside layer of the lung’s lining. The surgeon removes all visible cancerous tissue. It takes between 2 and 4 hours.
At the beginning of surgery, the team carefully positions the patient on their side. To access the chest cavity, the surgeon makes a long incision along the back called a thoracotomy. The incision begins near the top of the ribcage and runs parallel to the spine before extending outward near the bottom of the ribcage.
If there is cancer in the lower chest, the surgeon may perform a second incision to reach that area of the chest cavity. In some cases, surgeons remove the sixth rib to access the entire chest cavity.
The surgeon then removes the parietal pleura, the outside layer of the pleural lining. The surgeon will also remove other cancerous tissues, including any present on the chest wall lining, heart sac or diaphragm.
Get a Mesothelioma Treatment Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
In the decortication part, a surgeon removes cancerous or abnormal tissue from the lungs, chest wall or diaphragm. The surgeon typically performs this procedure after finishing the parietal pleurectomy. The surgeon removes any visible tumor growth and may surgically scrape the lung to ensure the removal of any malignant tissue.
“We’re finding that we’re able to remove all the tumor that’s visible,” said Dr. Andrea Wolf, director of the New York Mesothelioma Program at Mount Sinai. “That’s why there’s been a shift toward doing this lung-sparing procedure more so than in decades past.”
As the surgical team completes the procedure, they’ll take steps to prevent postoperative bleeding, such as suturing or cauterizing blood vessels. Some specialists have also integrated experimental targeted treatments such as photodynamic therapy, heated intrapleural chemotherapy or chemotherapy gels, which have shown promising results.
The final step is for the surgeon to stitch the incision closed. The decortication portion of a P/D takes about 2 to 3 hours.
Receive a free guide with the latest information on emerging treatments and clinical trials.
Get Yours NowPleurectomy/Decortication (P/D) is a lung-sparing approach to treating pleural mesothelioma. It allows patients to retain lung function while effectively removing tumors. The procedure has a good record of reducing mesothelioma symptoms and prolonging life.
While some surgeons debate the benefits and risks of P/D versus the more invasive extrapleural pneumonectomy (EPP) procedure, research studies show that P/D can lead to more prolonged survival. Because it’s associated with fewer complications and better quality of life, with only 1% to 2% of patients dying during or immediately after the surgery, most mesothelioma specialists today agree that P/D is preferable in cases where cancer tissue has not invaded the lung.
One mesothelioma survivor, Kevin Hession, reported that undergoing P/D significantly improved his ability to breathe and participate in daily activities, emphasizing the surgery’s impact on quality of life.
The main risk and side effect of a pleurectomy/decortication is an infection at the incision site. Every surgical procedure carries inherent risks. By knowing what to expect, patients can better prepare themselves and discuss worries with their healthcare providers. Here are the primary risks and side effects to consider:
While pleurectomy/decortication is generally considered a safer option compared to more invasive procedures, it is essential to acknowledge the risks and potential side effects associated with the surgery. Awareness of these factors can help patients prepare and address any concerns with their medical team.
Understanding the potential risks and side effects of pleurectomy/decortication can empower patients to approach their surgery with knowledge and confidence. Discussing any concerns with medical professionals can help ensure a smoother recovery process.
Not all people with a mesothelioma diagnosis are eligible for P/D. Surgeons assess each individual to ensure that P/D is the appropriate treatment. P/D can treat early-stage (stages 1 an 2) pleural mesothelioma. In these stages, the cancer is confined to the chest cavity and hasn’t spread to other areas of the body, so surgery can remove all cancerous tissue.
Kevin Hession underwent decortication surgery to remove all visible tumors in January 2022, about 5 months after being diagnosed with pleural mesothelioma. Kevin spoke with The Mesothelioma Center to share his experiences while recovering from surgery and to explain some lasting effects from the procedure.
Determining candidacy for pleurectomy/decortication is vital for ensuring patients receive the most appropriate treatment. Specific criteria can help identify those who may benefit most from this surgical option.
Individuals who are eligible for P/D may also benefit from additional therapies. These may include chemotherapy or radiation to destroy cancer cells further and prevent the progression or recurrence of disease.
Findings presented in 2023 raised questions about the efficacy of P/D and chemotherapy compared with chemotherapy alone. The study showed that chemotherapy alone may offer better outcomes than chemotherapy with surgery. The subject will require further study, and individuals should discuss all treatment options with their mesothelioma care team.
Several factors influence the decision to pursue pleurectomy/decortication. These factors deals with some factors you cannot control such as age and cancer stage.
By carefully considering these factors, patients can make informed decisions about their treatment options and work closely with their healthcare providers to find the best path forward.
Patients considering P/D should consult with a mesothelioma specialist. These experts can evaluate individual health conditions, provide personalized recommendations, and discuss potential risks and benefits associated with the procedure. Their insights can help patients make informed choices about their treatment plans.
Patients may meet in person or virtually with the surgeon and the surgical team. They can ask detailed questions, raise concerns and inquire about the surgeon’s success rate.
Receive a free recording of our webinar for expert tips on managing the side effects of surgery and other top mesothelioma treatments.
Get a RecordingPreparation for pleurectomy/decortication surgery involves several essential steps to ensure a successful outcome. Understanding what to expect can alleviate anxiety and help patients feel more confident as they approach their procedure.
Being well-prepared for surgery can contribute to a smoother experience and recovery. Here are the primary steps involved in preparing for pleurectomy/decortication:
Proper preparation for pleurectomy/decortication surgery is crucial for a successful experience. Patients can set themselves up for a positive surgical outcome by following pre-surgery steps and maintaining open communication with their healthcare team.
Most individuals require a hospital stay of about 2 weeks after P/D, so doctors monitor recovery closely. The staff can identify signs of complications such as infection, pneumonia or bleeding and take appropriate action. The care team can use the time to teach patients deep-breathing exercises and other therapies to aid recovery.
Total recovery from surgery usually takes several more weeks after hospital discharge. The care team will provide detailed instructions on how to continue recovery at home and arrange for any necessary visits from occupational and pulmonary therapists. Some patients may be eligible for complementary therapies, such as pulmonary rehabilitation. Following care instructions and attending follow-up appointments will safeguard patient health.
Pleurectomy and decortication have a 90% success rate in reducing symptoms and can increase survival time to about 20 months. It’s not considered a cure for mesothelioma, but this surgery is among the most effective treatment options when combined with a multimodal mesothelioma treatment approach.
The median survival after P/D is about 20 months, depending on other prognostic factors, such as the stage of mesothelioma, treatment approach and patient health status. Multimodal treatment protocols may improve survival rates.
P/D typically takes between 4 to 6 hours to complete.
While P/D can remove tumors and alleviate symptoms, it is not considered a cure for mesothelioma. Comprehensive treatment often involves multiple modalities.
P/D is often seen as a less invasive option than extrapleural pneumonectomy, particularly for patients looking to preserve lung function.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2024, October 31). Pleurectomy/Decortication for Mesothelioma. Asbestos.com. Retrieved November 14, 2024, from https://www.asbestos.com/treatment/surgery/pleurectomy/
Selby, Karen. "Pleurectomy/Decortication for Mesothelioma." Asbestos.com, 31 Oct 2024, https://www.asbestos.com/treatment/surgery/pleurectomy/.
Selby, Karen. "Pleurectomy/Decortication for Mesothelioma." Asbestos.com. Last modified October 31, 2024. https://www.asbestos.com/treatment/surgery/pleurectomy/.
A medical doctor who specializes in mesothelioma or cancer treatment reviewed the content on this page to ensure it meets current medical standards and accuracy.
Please read our editorial guidelines to learn more about our content creation and review process.
Dr. Andrea Wolf is the Director of the New York Mesothelioma Program at Mount Sinai in New York City. She focuses on multidisciplinary treatment, clinical research, community outreach and education.
Mesothelioma Center - Vital Services for Cancer Patients & Families doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.